We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov Menu

Falls Prevention in Osteoporosis

This study has been completed.
ClinicalTrials.gov Identifier:
First Posted: February 8, 2007
Last Update Posted: February 25, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ZonMw: The Netherlands Organisation for Health Research and Development
Information provided by:
Sint Maartenskliniek
The purpose of this study is to determine wether a falls prevention program can reduce fall incidence in people with osteoporosis.

Condition Intervention
Osteoporosis Procedure: Falls Prevention Program

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Falls Prevention for People With Increased Risk of Fractures as a Result of Osteoporosis: a Randomized Controlled Study on the Effects of a Modified Program

Resource links provided by NLM:

Further study details as provided by Sint Maartenskliniek:

Primary Outcome Measures:
  • Fall incidence, which is measured by monthly fall registration cards

Secondary Outcome Measures:
  • Obstacle avoidance performance
  • Fear of falling (ABC)
  • Activity level (LAPAQ)

Enrollment: 96
Study Start Date: December 2005
Study Completion Date: December 2009
Primary Completion Date: May 2009 (Final data collection date for primary outcome measure)
Detailed Description:

Falling is a major health problem in the elderly causing physical and psychosocial problems. People with osteoporosis are at higher risk for fractures due to falling, because of decreased bone strength. The 'Nijmegen Falls Prevention Program" (NFPP) (Weerdesteyn et al, 2006) has been shown to reduce fall incidence rates by 46% in healthy community-dwelling elderly. This program was adapted in order to meet the specific demands and constraints of people with osteoporosis.

The contents of the program are an obstacle course, walking exercises, the practice of fall techniques, adjustment of gait abnormalities, weight bearing exercises and educational sessions.

The effectiveness of the program will be evaluated in a randomized clinical trial. Primary outcome measure is fall incidence. Additionally, laboratory assessments of gait and obstacle avoidance will be conducted in conjunction with questionnaires about balance confidence and activity level.


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   65 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • osteoporosis (DXA T-score < -2.5 in hip and/or vertebrae)
  • able to walk at least 15 minutes without an helping device
  • 65 years or older
  • community dwelling
  • at least one fall in the prior year

Exclusion Criteria:

  • severe cardiac, pulmonary or musculoskeletal disorders
  • pathologies associated with increased fall risks (i.e. stroke or Parkinson's disease)
  • use of psychotropic drugs
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00432692

Sint Maartenskliniek
Nijmegen, Netherlands
Sponsors and Collaborators
Sint Maartenskliniek
ZonMw: The Netherlands Organisation for Health Research and Development
Principal Investigator: Ellen Smulders, MSc Sint Maartenskliniek
Principal Investigator: Vivian Weerdesteyn, PhD Sint Maartenskliniek
Principal Investigator: Wim van Lankveld, PhD Sint Maartenskliniek
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00432692     History of Changes
Other Study ID Numbers: SMK001
First Submitted: February 7, 2007
First Posted: February 8, 2007
Last Update Posted: February 25, 2010
Last Verified: April 2007

Keywords provided by Sint Maartenskliniek:
obstacle avoidance

Additional relevant MeSH terms:
Bone Diseases, Metabolic
Bone Diseases
Musculoskeletal Diseases
Metabolic Diseases